Epithelial Clara Cell Injury Occurs in Bronchiolitis Obliterans Syndrome After Human Lung Transplantation

Bronchiolitis obliterans syndrome (BOS) is a condition of progressive airflow obstruction that affects a majority of lung transplant recipients and limits long‐term posttransplant survival. Although epithelial injury appears central to the development of BOS, little is known regarding the specific epithelial cell types that are affected in this condition. We hypothesized that BOS would involve preferential injury to the secretory Clara cells that function in innate defense and epithelial repair. To test this hypothesis, we assessed tissue transcript, tissue protein and lung fluid protein expression of Clara cell secretory protein (CCSP), a marker for Clara cells, in lung transplant recipients with BOS, BOS‐free patients and in donor controls. Our results demonstrate that CCSP tissue transcript and protein expression are significantly reduced in lung transplant recipients with BOS compared to BOS‐free or donor controls. In addition, we demonstrate that CCSP protein levels are significantly reduced in the lung fluid of patients with BOS compared to BOS‐free controls, in cross‐sectional and longitudinal analysis. Collectively, these complementary results illustrate that BOS involves a selective alteration in the distribution and function of bronchiolar Clara cells.

[1]  R. Eils,et al.  Proteomic Bronchiolitis Obliterans Syndrome Risk Monitoring in Lung Transplant Recipients , 2011, Transplantation.

[2]  T. Mohanakumar,et al.  Lipid raft facilitated ligation of K-alpha1-tubulin by specific antibodies on epithelial cells: Role in pathogenesis of chronic rejection following human lung transplantation. , 2010, Biochemical and biophysical research communications.

[3]  S. Palmer,et al.  Gastroesophageal reflux and altered motility in lung transplant rejection , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[4]  D. Howell,et al.  Acute cellular rejection and humoral sensitization in lung transplant recipients. , 2010, Seminars in respiratory and critical care medicine.

[5]  N. Kaminski,et al.  Clara cells attenuate the inflammatory response through regulation of macrophage behavior. , 2010, American journal of respiratory cell and molecular biology.

[6]  F. Watt,et al.  Stem cells are dispensable for lung homeostasis but restore airways after injury , 2009, Proceedings of the National Academy of Sciences.

[7]  B. Stripp,et al.  Reparative capacity of airway epithelium impacts deposition and remodeling of extracellular matrix. , 2009, American journal of respiratory cell and molecular biology.

[8]  S. Palmer,et al.  Acute rejection and humoral sensitization in lung transplant recipients. , 2009, Proceedings of the American Thoracic Society.

[9]  B. Stripp,et al.  Maintenance and Repair of the Bronchiolar Epithelium , 2022 .

[10]  O. Cummings,et al.  IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. , 2007, The Journal of clinical investigation.

[11]  L. Snyder,et al.  Lung transplantation at Duke University Medical Center. , 2007, Clinical transplants.

[12]  L. Snyder,et al.  Immune mechanisms of lung allograft rejection. , 2006, Seminars in respiratory and critical care medicine.

[13]  E. Toskala,et al.  Elevation of susceptibility to ozone-induced acute tracheobronchial injury in transgenic mice deficient in Clara cell secretory protein. , 2006, Toxicology and applied pharmacology.

[14]  M. Steele,et al.  Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients. , 2006, Chest.

[15]  G. Nelsestuen,et al.  Analysis of chronic lung transplant rejection by MALDI‐TOF profiles of bronchoalveolar lavage fluid , 2006, Proteomics.

[16]  M. Nord,et al.  Decreased Serum Levels of Clara Cell Secretory Protein (CC16) Are Associated with Bronchiolitis Obliterans and May Permit Early Diagnosis in Patients after Allogeneic Stem-Cell Transplantation , 2005, Transplantation.

[17]  D. Schwartz,et al.  Innate immunity influences long-term outcomes after human lung transplant. , 2005, American journal of respiratory and critical care medicine.

[18]  M. Steele,et al.  Gastroesophageal reflux disease in lung transplant recipients , 2003, Clinical transplantation.

[19]  K. Harrod,et al.  Clara Cell Secretory Protein Modulates Lung Inflammatory and Immune Responses to Respiratory Syncytial Virus Infection1 , 2003, The Journal of Immunology.

[20]  S. Randell,et al.  Hierarchical contributions of allorecognition pathways in chronic lung rejection. , 2003, American journal of respiratory and critical care medicine.

[21]  K. Savik,et al.  Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. , 2002, Transplantation.

[22]  B. Stripp,et al.  Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. , 2002, The American journal of pathology.

[23]  M. Nord,et al.  Decreased serum and bronchoalveolar lavage levels of clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients1 , 2002, Transplantation.

[24]  Marshall Hertz,et al.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  B. Stripp,et al.  Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. , 2000, The American journal of pathology.

[26]  C. Plopper,et al.  Early events in naphthalene-induced acute Clara cell toxicity: comparison of membrane permeability and ultrastructure. , 1999, American journal of respiratory cell and molecular biology.

[27]  B. Stripp,et al.  Clara cell secretory protein-deficient mice differ from wild-type mice in inflammatory chemokine expression to oxygen and ozone, but not to endotoxin. , 1999, Experimental lung research.

[28]  B. Stripp,et al.  Clara cell secretory protein decreases lung inflammation after acute virus infection. , 1998, American journal of physiology. Lung cellular and molecular physiology.